Media
Filter:
News Release 17 January 2023
Helping Rare Diseases Emerge from the Shadows to Take Centre Stage
Actigen’s Managing Director Michael Braunagel shares his thoughts on how the rare disease treatment market has been transformed in recent years and begun to receive greater industry recognition.
Blog 15 August 2022
From cancer research pioneer to rare disease breakthroughs – Michael’s 30-year journey
Our very own Michael Braunagel takes us through his three-decade-long career spanning three countries, ranging from cutting edge cancer research to developing a potentially groundbreaking clinical treatment in the field of rare diseases.
